Prostate Cancer Clinical Trial
Trial of Modifications to Radical Prostatectomy
Summary
This trial will evaluate whether the following aspect of surgical technique influence outcome: Lymph node dissection. In some patients, scans taken before surgery show that a lymph node has cancer. Surgeons make sure to remove those affect lymph nodes and all other lymph nodes in the area. However, it is not known whether removing lymph nodes helps prostate cancer patients whose scans do not show positive nodes. In this study, patients with clear scans will either receive a lymph node dissection or not."
Eligibility Criteria
Inclusion Criteria:
Patients do not have to be eligible for both modifications to be included in the study.
Lymphadenectomy vs no lymphadenectomy:
Patients 21 years or older scheduled for radical prostatectomy for treatment of prostate cancer with one of the consenting surgeons at MSKCC
Hemostatic agent vs. no hemostatic agent
Patients 21 years or older scheduled for minimally invasive radical prostatectomy for the treatment of prostate cancer with one of the consenting surgeons at MSKC
Exclusion Criteria:
Lymphadenectomy vs no lymphadenectomy
Presence of positive/suspicious pelvic nodes on MRI, CT or PSMA scan (positive/suspicious defined as a pelvic node >15mm in short axis or a node with abnormal morphology such as roundness or irregularity or loss of fatty hilum
Any prior pelvic radiation therapy used to treat prostate cancer
Hemostatic agent vs. no hemostatic agent
No additional exclusion criteria
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 3 Locations for this study
Basking Ridge New Jersey, 07920, United States More Info
New York New York, 10065, United States More Info
Principal Investigator
How clear is this clinincal trial information?